ICD-10 Casefinding List, 2017 (Based on US ICD-10 Cause of Death List)
(EFFECTIVE DATES: 1/1/2017-12/31/2017)

These tables are also available in a printable version (PDF).

World Health Organization. International Statistical Classification of Diseases and Related Health problems, Tenth Revision. Geneva: World Health Organization. 2007

Please refer to your standard setter(s) for specific reporting requirements before using the Casefinding List.

COMPREHENSIVE ICD-10 Casefinding Code List for Reportable Tumors
ICD-10 Code Explanation of ICD-10 Code
B21._ Human Immunodeficiency virus [HIV] disease with malignant neoplasms
C00._ - C97._ Malignant neoplasms
Note: Pilocytic/juvenile astrocytoma M-9421 moved from behavior /3 (malignant) to /1 (borderline malignancy) in ICD-O-3. However, SEER registries will CONTINUE to report these cases and code behavior as /3 (malignant).
D00._ - D09._ In-situ neoplasms
Note: Carcinoma in situ of the cervix (CIN III-8077/2) and Prostatic Intraepithelial Carcinoma (PIN III-8148/2) are not reportable.
D18.0 Hemangioma, any site
Note: Includes Hemangiomas of Brain, Other parts of nervous system and endocrine glands, which are reportable.
D32._ Benign neoplasm of meninges (cerebral, spinal and unspecified)
D33._ Benign neoplasm of brain and other parts of central nervous system
D35.2 Benign neoplasm of pituitary gland
D35.3 Benign neoplasm of craniopharyngeal duct
D35.4 Benign neoplasm of pineal gland
D42._ Neoplasm of uncertain or unknown behavior of meninges
D43._ Neoplasm of uncertain or unknown behavior of brain and central nervous system
D44.3 - D44.5 Neoplasm of uncertain or unknown behavior of pituitary gland, craniopharyngeal duct and pineal gland
D45 Polycythemia vera (9950/3)
D46._ Myelodysplastic syndromes (9980, 9982, 9983, 9985, 9986, 9989, 9991, 9992)
D47.1 Chronic myeloproliferative disease (9960/3, 9961/3, 9963/3)
D47.3 Esssential (hemorrhagic) thrombocythemia (9962/3)
D47.7 Other specified neoplasms of uncertain/unknown behavior of lymphoid, hematopoietic (9965/3, 9966/3, 9967/3, 9971/3, 9975/3, 9987/3)
D47.9 Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified (9960/3, 9961/3, 9970/1, 9931/3)
D48.9 Neoplasm of uncertain or unknown behavior, unspecified
Note: Review code for uncertain behavior brain, CNS tumors and reportable benign endocrine glands

NOTE: Cases with these codes should be screened as registry time allows. Experience in the SEER registries has shown that using the supplemental list increases casefinding for benign brain and CNS, hematopoietic neoplasms, and other reportable diseases.

SUPPLEMENTAL LIST ICD-10
ICD-10 Code Explanation of ICD-10 Code
B20._, B22 - B24 Human immunodeficiency virus [HIV] disease with other diseases
Note: Excludes HIV with malignancy (B21), see reportable list
B99 Other infectious diseases (Human papillomavirus, Retrovirus-HTLV types I, II, 2)
D10._ - D31._,
D34, D35.0,
D35.1, D35.5 - D35.9,
D36._
Benign neoplasms (see "must collect" list for reportable benign neoplasms)
Note: Screen for incorrectly coded malignancies or reportable by agreement tumors
Note: Borderline cystadenomas M-8442, 8451, 8462, 8472, 8473, of the ovaries moved from behavior /3 (malignant) to /1 (borderline malignancy) in ICD-O-3. SEER registries are not required to collect these cases for diagnoses made 1/1/2001 and after. However, cases diagnosed prior to 1/1/2001 should still be abstracted and reported to SEER.
D37._ - D41._ Neoplasms of uncertain or unknown behavior (see "must collect" list for reportable neoplasms of uncertain or unknown behavior)
Note: Screen for incorrectly coded malignancies or reportable by agreement tumors
D44.0 - D44.2,
D44.6 - D44.9
Neoplasm of uncertain or unknown behavior of other endocrine glands (see "must collect" list for D44.3-D44.5)
Note: Screen for incorrectly coded malignancies or reportable by agreement tumors
D47.0 Histiocytic and mast cell tumors of uncertain behavior
D47.2 Monoclonal gammopathy
Note: Screen for incorrectly coded Waldenstrom's macroglobulinemia
D47.7 Other specified neoplasms of uncertain or unknown behavior of lymphoid, hematopoietic and related tissue
Note: Screen for Castleman disease that is associated with lymphoma
D48._ Neoplasms of uncertain or unknown behavior
Note: Screen for incorrectly coded malignancies or reportable by agreement tumors
D61.1 Drug-induced aplastic anemia (also known as “aplastic anemia due to antineoplastic chemotherapy)
D61.8 Other specified aplastic anemias (drug induced pancytopenia)
Note: screen for blood disorders due to neoplasm
D64.8 Other specified anemias
Note: Includes anemia due to neoplastic disease or antineoplastic chemotherapy
D69.4 - D69.6 Other thrombocytopenia
Note: Screen for incorrectly coded thrombocythemia
D70 Agranulocytosis (Note: Screen for blood disorders due to neoplasm)
D72.1 Eosinophilia (Note: Code for eosinophilia (9964/3). Not every case of eosinophilia is with a malignancy. Diagnosis must be "Hypereosonophilic syndrome" to be reportable.)
D75.8 Other specified diseases of blood and blood-forming organs
D76._ Certain diseases involving lymphoreticular tissue and reticulohistiocytic system
D89.1 Cryoglobulinemia
D89.2 Hypergammaglobulinemia, unspecified
Note: screen for blood disorders due to neoplasm
D89.3 Immune reconstitution syndrome
Note: screen for blood disorders due to neoplasm
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified
Note: screen for mast cell disorders
E34.0 Carcinoid syndrome
Note: Part of the paraneoplastic syndrome
E34.1 Other hypersecretion of intestinal hormones
Note: Part of the paraneoplastic syndrome
E83.5 Disorders of calcium metabolism (hypercalcemia)
Note: Part of the paraneoplastic syndrome
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
Note: Screen for incorrectly coded Waldenstrom's macroglobulinemia
E88.8 Other specified metabolic disorders (Tumor lysis syndrome)
G13.0 Paraneoplastic neuromyopathy and neuropathy (carcinomatous neuromyopathy)
G13.1 Other systemic atrophy primarily affecting central nervous system in neoplastic disease (paraneoplastic limbic encephalopathy)
G73.1 Lambert-Eaton syndrome
G99.2 Myelopathy in diseases classified elsewhere (underlying disease neoplasm)
H47.4 Disorders of optic chiasm
H47.5 Disorders of other visual pathways
H47.6 Disorders of visual cortex
J34.8 Other specified disorders of nose and nasal sinuses
J91 Pleural effusion in conditions classified elsewhere
J93.1 Other spontaneous pneumothorax
K12.3 Oral mucositis (ulcerative)
K22.7 Barrett’s esophagus
K62.7 Radiation proctitis
K62.8 Other specified diseases of anus and rectum (AIN I, AIN II)
K92.8 Other specified diseases of digestive system (mucositis due to cancer therapy)
M36.0 Dermato(poly)myositis in neoplastic disease
M36.1 Arthropathy in neoplastic disease
M84.4 Pathological fracture, not elsewhere classified
M90.6 Osteitis deformans in neoplastic disease
N42.8 Disorder of prostate (PIN I and PIN II)
N76.8 Other specified inflammation of vagina and vulva
N87._ Dysplasia of cervix (CIN I and CIN II)
N89.0-N89.3 Dysplasia of vagina (VAIN I and VAIN II)
N90.0-N90.3 Dysplasia of vulva (VIN I and VIN II)
O01._ Hydatidiform mole (Note: benign tumor that can become malignant. If malignant, it should be reported as Choriocarcinoma (9100/3) with malignancy code in c00-c97))
O90.8 Other complications of the puerperium, not elsewhere classified
Q85.0 Neurofibromatosis (nonmalignant) (9540/1) (Note: Neurofibromatosis by itself is not reportable, but it can lead to a reportable condition)
R18 Ascites (malignant)
R52.9 Pain, unspecified (neoplasm related pain, cancer associated pain)
R53 Malaise and fatigue (neoplasm related fatigue)
R59._ Enlarged lymph nodes
R85.6 Abnormal findings on cytological/histological exam of digestive organs
R87.6 Abnormal findings on cytological/histological exam of female genital organs
R92 Abnormal findings on diagnostic imaging of breast
T38.6 Poisoning by antigonadotrophins, antiestrogens, and antiandrogens, not elsewhere classified
T38.8 Poisoning by other and unspecified hormones and their synthetic substitutes
T38.9 Poisoning by other and unspecified hormone antagonists
T45.1 Poisoning by antineoplastic and immunosuppressive drugs
T45.8 Poisoning by other primarily systemic and hematologic agents
T45.9 Poisoning by other primarily systemic and hematological agent, unspecified
T66 Unspecified effects of radiation
T80.1 Vascular complications following infusion, transfusion, and therapeutic injection
T80.2 Infections following infusion, transfusion, and therapeutic injection
T80.8 Other complications following infusion, transfusion and therapeutic injection
T86.0 Failure and rejection of transplanted organs and tissues: Bone-marrow transplant rejection
Y42.1 Other and unspecified hormone antagonists (poisoning)
Y42.6 Adverse reaction to antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified
Y43.1 - Y43.4 Adverse effects in therapeutic use, antineoplastic products or drugs
Y43.9 Adverse effects in therapeutic use, primarily systemic agent, unspecified
Note: Includes poisoning by primarily systemic and hematological agents
Y63.2 Failure in dosage, overdose of radiation given during therapy
Note: Includes adverse reaction to radiation
Y84.2 Abnormal reaction, radiological procedure and radiotherapy (radiation sickness)
Y84.9 Other medical procedures (abnormal reactions, complications from central venous catheters)

Return to top